5-Amino-3-phenyl-2,3-dihydrooxazole-4-carboxamide

Catalog No. :
ACXHMJ401
CAS No. :
15783-70-7
Molecular Formula :
C10H11N3O2
Molecular Weight :
205.22

IUPAC Name:5-amino-3-phenyl-2,3-dihydrooxazole-4-carboxamide

5-Amino-3-phenyl-2,3-dihydrooxazole-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$136.00Login to see priceInquiryInquiry
100mg95%$193.00Login to see priceInquiryInquiry
250mg95%$268.00Login to see priceInquiryInquiry
1g95%$644.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Amino-3-phenyl-2,3-dihydrooxazole-4-carboxamide
IUPAC Name5-amino-3-phenyl-2,3-dihydrooxazole-4-carboxamide
MDL No.0
Molecular FormulaC10H11N3O2
Molecular Weight205.22
SMILESO=C(C1=C(N)OCN1C2=CC=CC=C2)N
InChI KeyRFYWLNYPMJMCBB-UHFFFAOYSA-N
Synonym5-Amino-3-phenyl-oxazole-4-carboxamide;5-AMINO-3-PHENYL-1,2-OXAZOLE-4-CARBOXAMIDE;4-Isoxazolecarboxamide, 5-amino-3-phenyl-;5-AMINO-3-PHENYL-ISOXAZOLE-4-CARBOXYLIC ACID AMIDE;5-Amino-3-phenylisoxazole-4-carboxamide
CAS No.15783-70-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXHMJ401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACXHMJ401 route product structure diagram
    ACXHMJ40115783-70-7
Inquiry

2. ACXHMJ401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACXHMJ401 route product structure diagram
    ACXHMJ40115783-70-7
Inquiry

Comments (0)